Skip to main content
. Author manuscript; available in PMC: 2015 Jan 8.
Published in final edited form as: Am J Transplant. 2013 Sep 5;13(11):3021–3030. doi: 10.1111/ajt.12417

Figure 2. Activation and cytokine production of alloreactive T cells are diminished in the presence of anti-CD154 dAbs.

Figure 2

(A) Representative histograms of CD44 expression on splenic CD4+ and CD8+ T cells isolated from grafted mice at day 14. (B) Frequencies of CD44hi cells among CD4+ and CD8+ T cell populations. Treatment with MR-1, 7E1-G2b or CD154 dAbs results in the reduction of CD44 expression on both CD4+ and CD8+ cells. (C) Representative flow plots of intracellular cytokine staining of recipient splenocytes, gated on CD8+ T cells. 106 recipient splenocytes were incubated with 2×106 BALB/c stimulator splenocytes for 5 hours and then fixed and permeabilized before being stained for FACS analysis. (D) Frequencies and absolute numbers of cytokine-producing CD8+ T cells. Treatment with MR-1, 7E1-G2b or CD154 dAbs results in the reduction of percentage of multicytokine producing CD8+ T cells. Data are cumulative of two separate experiments with a total of 8 to 10 mice per group. ** p < 0.01, *** p < 0.001.